@inproceedings{Smolen_2018,
title={AB0928 Ustekinumab and tnf inhibitors in psoriatic arthritis: first follow-up data from a routine care study in 8 european countries (PSABIO)},
url={http://dx.doi.org/10.1136/annrheumdis-2018-eular.6939},
DOI={10.1136/annrheumdis-2018-eular.6939},
booktitle={Psoriatic arthritis},
publisher={BMJ Publishing Group Ltd and European League Against Rheumatism},
author={Smolen,
J.S. and Bergmans,
P. and Bondareva,
I. and de Vlam,
K. and Gremese,
E. and Joven-Ibáñez,
B. and Korotaeva,
T.V. and Nurmohamed,
M.T. and Sfikakis,
P.P. and Siebert,
S. and Smirnov,
P. and Theander,
E. and D’Abrosca,
V. and Gossec,
L.},
year={2018},
month=jun }